Archived Grant Opportunity View - GO3329

The Medical Research Future Fund - Emerging Priorities and Consumer Driven Research Initiative is designed to support high quality research that improves patient care, translates new discoveries and encourages joint collaboration of consumers and researchers in undertaking research in emerging priority areas.

The objectives of the 2019 Mental Health Pharmacogenomics Grant Opportunity are to:

• reduce barriers to clinical uptake of pharmacogenomics testing for patients presenting with neuropsychiatric conditions
• address gaps in evidence related to the application of pharmacogenomics for neuropsychiatric conditions
• encourage research that combines new or existing technologies with large-scale data, machine learning, clinical information, or patient biomarkers to develop new or refine existing tests that facilitate improved personalisation and efficacy of psychotropic medication regimens.

This grant opportunity is being administered by NHMRC on behalf of the Commonwealth Department of Health. 

Further information on the Medical Research Future Fund and the Emerging Priorities and Consumer Driven Research Initiative is available on the Department’s website at: https://www.health.gov.au/mrff

Applications will only be accepted from NHMRC-approved Administering Institutions. A list of NHMRC-approved Administering Institutions is available for download from GrantConnect-GO documents, and on the NHMRC website at:

https://nhmrc.gov.au/funding/manage-your-funding/nhmrcs-administering-institutions

Applications must satisfy all the requirements set out in the 2019 Mental Health Pharmacogenomics Grant Guidelines.

$7,000,000.00

Applications must be submitted electronically using NHMRC’s online Research Grants Management System (RGMS).